Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Vascular reactivity in patients with undifferentiated connective tissue diseases
Atherosclerosis, 03/06/09
Mosca M et al. – Data suggest that in the absence of traditional risk factors, inactive systemic autoimmune diseases impair nitric oxide (NO)-dependent but also endothelium-independent vasodilation selectively in the microcirculation in young patients with undifferentiated connective tissue diseases (UCTD).
Methods- An investigation of endothelial function in the peripheral circulation of UCTD pts (n=15; mean age 39 yrs) with inactive disease and w/o cv risk factors
- Endothelial function in the brachial conduit artery was assessed by flow mediated dilation (FMD), and response to glyceryl trinitrate
- Forearm microcirculation measured by blood flow changes in response to intra-arterial acetylcholine (Ach) and sodium nitroprusside (SNP)
- NO availability evaluated by repeating Ach in the presence of intraarterial NG-monomethyl-l-arginine (l-NMMA), an NO synthase inhibitor
- FMD and response to GTN were similar in UCTD pts and controls
- UCTD pts showed a reduced response to Ach and SNP vs controls
- In healthy controls l-NMMA infusion reduced the vascular response to Ach vs UCTD pts (no effect)
- In UCTD pts, vascular responses were unrelated to clinical manifestations or autoantibody profile
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Sildenafil on digital ulcers in systemic sclerosis - analysis from a single centre pilot study
Annals of Rheumatic Diseases, 11/23/09
Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09
Sponsor
Article Search
Sponsor


See Latest Articles


